Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Skeletal imaging in metastatic disease.

¹University College and Middlesex School of Medicine, London, UK.

Current Opinion in Radiology

|December 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Simultaneous PET/MRI in frontotemporal dementia.

European journal of nuclear medicine and molecular imaging·2012

Same author

The incremental value of dual modality PET/CT imaging over PET imaging alone in advanced colorectal cancer.

The Indian journal of surgery·2012

Same author

The role of ¹⁸fluoro-deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2010

Same author

Sentinel node imaging in breast cancer using superficial injections: technical details and observations.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2009

Same author

Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT).

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2009

Same author

Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study.

Hormones and behavior·2007

Same journal

Radiology of thoracic trauma.

Current opinion in radiology·1992

Same journal

Computed tomographic diagnosis of diffuse lung disease.

Current opinion in radiology·1992

Same journal

Thoracic magnetic resonance imaging.

Current opinion in radiology·1992

Same journal

Radiology of lung cancer.

Current opinion in radiology·1992

Same journal

Imaging of the mediastinum and hila.

Current opinion in radiology·1992

Same journal

Pediatric chest imaging.

Current opinion in radiology·1992

See all related articles

Radionuclide bone scans remain essential for detecting bone metastases from common cancers like breast, prostate, and lung. New therapeutic tracers offer promising pain relief for patients with skeletal secondary tumors.

Area of Science:

Nuclear Medicine
Oncology
Radiology

Background:

Radionuclide bone scanning is a standard diagnostic tool for detecting bone metastases.
Primary cancers of the breast, prostate, and lung frequently metastasize to the skeleton.
Magnetic Resonance (MR) imaging shows high sensitivity for bone marrow involvement.

Purpose of the Study:

To review current topics on the role of bone scanning in patients with metastatic bone disease.
To discuss the utility of tumor markers, such as prostate-specific antigens, in diagnosing prostate cancer metastasis.
To highlight advancements in bone-seeking radionuclide tracers for both diagnostic and therapeutic applications.

Main Methods:

Review of current literature on radionuclide bone scanning and related imaging techniques.

Related Experiment Videos

Discussion of the diagnostic advantages of bone scanning (simplicity, cost-effectiveness, whole-body screening).

Exploration of the emerging therapeutic applications of novel bone-seeking radiotracers.

Main Results:

Bone scanning remains the preferred method for whole-body skeletal metastasis screening due to its practicality, despite MR imaging's sensitivity.
Prostate-specific antigen (PSA) levels are increasingly important in managing prostate cancer metastasis.
New bone-seeking tracers show significant promise for palliative pain management in patients with widespread bone metastases.

Conclusions:

Radionuclide bone scanning is a cost-effective and efficient method for evaluating bone metastases.
Therapeutic applications of bone-seeking radionuclides represent a promising advancement in palliative care for skeletal metastases.
Single-photon emission computed tomography (SPECT) enhances the localization accuracy of radionuclide uptake in the skeleton.